Combinations of potassium channel openers and sodium channel inhibitors or active substances influencing sodium channels in order to treat painful conditions
Details for Australian Patent Application No. 2004283472 (hide)
International Classifications
Event Publications
18 May 2006 PCT application entered the National Phase
PCT publication WO2005/039576 Priority application(s): WO2005/039576
17 April 2008 Alteration of Name
The name of the applicant has been altered to MEDA Pharma GmbH & Co. KG Amendments
11 February 2010 Application Accepted
Published as AU-B-2004283472
10 June 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004283475-Fungicidal active combinations spiroxamine, prothioconazole and tebuconazole
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser